Ryosuke Shirasaki - Concepedia

Author

Ryosuke Shirasaki

Dana-Farber Cancer Institute ORCID

Also Known As

R. Shirasaki, Ryosuke Shirasaki

108

Publications

729

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Teikyo University Harvard University Broad Institute Emory University

About

Ryosuke Shirasaki is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	393
2	Immunology	4	4	113
3	Cell Biology	3	3	336
4	Allergy	2	2	37
5	Pathology	1	1	20

Ryosuke Shirasaki

Publications

596

Citations

H-Index

Page 1

	Year	Citations
An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence Eugen Dhimolea, Ricardo De Matos Simoes, Dhvanir Kansara, Cancer Cell Tumor BiologyOncogenic AgentMedicineTumor SuppressorRadiation Oncology	2021	246
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins Ryosuke Shirasaki, Geoffrey M. Matthews, Sara Gandolfi, Cell Reports	2021	105
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression Vikas A. Gupta, Benjamin G. Barwick, Shannon M. Matulis, Blood	2021	78
Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers Olli Dufva, Sara Gandolfi, Jani Huuhtanen, Immunity ImmunologyNk CellsImmunotherapeuticsImmunotherapyCancer Biology	2023	56
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias Ricardo De Matos Simoes, Ryosuke Shirasaki, Sondra L. Downey-Kopyscinski, Nature Cancer Genome-scale Functional GenomicsTumor BiologyHematological MalignancyFunctional GenomicsMixed-phenotype Acute Leukemia	2023	34
Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus Hirotoshi Kikuchi, Tadashi Yamamoto, Kurumi Asako, Modern Rheumatology VasculitisImmunologyDermatologyImmunotherapyHematology	2011	22
Molecular Analysis of Chronic Eosinophilic Leukemia with t(4;10) Showing Good Response to Imatinib Mesylate Haruko Tashiro, Ryosuke Shirasaki, Mitsuho Noguchi, International Journal of Hematology Hematological MalignancyMalignant Blood DisorderMolecular AnalysisHematologyImmunology	2006	20
Interleukin-1β Promotes the Expression of CD34 and Granulocyte Colony-Stimulating Factor-Receptor in Adult Dermal Fibroblasts Haruko Tashiro, Ryosuke Shirasaki, Yoko Oka, Blood	2011	20
Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus Hirotoshi Kikuchi, Tadashi Yamamoto, Kurumi Asako, Modern Rheumatology VasculitisImmunologyDermatologyImmunotherapyHematology	2012	15

Page 1